Lucira Health to Participate in William Blair 41st Annual Growth Stock Conference
May 25 2021 - 7:00AM
Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a
medical technology company focused on the development and
commercialization of transformative and innovative infectious
disease test kits, today announced that the company will be
participating in the William Blair 41st Annual Growth Stock
Conference.
Lucira Health’s management is scheduled to participate in the
conference on Wednesday, June 2, 2021, at 10:40 a.m. PT / 1:40 p.m.
ET. Interested parties can access the live and archived webcast at
ir.lucirahealth.com.
About Lucira HealthLucira Health is a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits.
Lucira’s testing platform produces lab quality molecular testing in
a single-use, consumer-friendly, palm size test kit powered by two
AA batteries. Lucira designed its test kits to provide accurate,
reliable and on-the-spot molecular tests results anywhere and
anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One
(RX) Test Kits are designed to provide a clinically relevant
COVID-19 result within 30 minutes from sample collection. For more
information, visit www.lucirahealth.com.
Investor Contact Greg Chodaczek
Investorrelations@lucirahealth.com347-620-7010
Media Contact Kevin Knight
media@lucirahealth.com 206-451-4823
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Apr 2023 to Apr 2024